These platforms are responsive to
the following Industrial segments
Transtoxbio offers human sourced cell/tissue based configured primary platforms/systems that can be integrated in your discovery, development, pre-clinical safety and efficacy testings predicting for clinics
Need Invitro platforms for CROs, Pharma R&D, or Biotech R&D companies?
Transcell’s Transtoxbio vertical was created to offer human surrogate cell/tissue in vitro systems to meet the need of investigations adopting next generation and alternative approaches in preclinical, clinical testings.